ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 66 filers reported holding ARBUTUS BIOPHARMA CORP in Q3 2020. The put-call ratio across all filers is 1.33 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $10,431,000 | +1.3% | 3,332,616 | -10.1% | 2.35% | -47.1% |
| Q4 2019 | $10,300,000 | +714.2% | 3,705,128 | +509.2% | 4.44% | +1141.3% |
| Q2 2019 | $1,265,000 | -56.1% | 608,151 | -24.4% | 0.36% | -65.4% |
| Q1 2019 | $2,880,000 | -52.5% | 804,446 | -49.2% | 1.04% | -62.8% |
| Q4 2018 | $6,060,000 | -76.0% | 1,582,275 | -40.9% | 2.78% | -66.5% |
| Q3 2018 | $25,296,000 | +30.7% | 2,676,825 | +0.9% | 8.29% | +25.7% |
| Q2 2018 | $19,358,000 | +160.7% | 2,651,825 | +78.5% | 6.60% | +114.3% |
| Q1 2018 | $7,426,000 | +877.1% | 1,485,245 | +886.3% | 3.08% | +477.7% |
| Q4 2017 | $760,000 | – | 150,592 | – | 0.53% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 340,000 | $1,459,000 | 0.53% |
| RTW INVESTMENTS, LP | 4,733,323 | $20,306,000 | 0.31% |
| APIS CAPITAL ADVISORS, LLC | 70,000 | $300,000 | 0.29% |
| Hudson Bay Capital Management LP | 1,800,000 | $7,722,000 | 0.10% |
| COWEN AND COMPANY, LLC | 249,215 | $1,069,000 | 0.05% |
| Kerrisdale Advisers, LLC | 100,000 | $429,000 | 0.05% |
| Woodline Partners LP | 496,172 | $2,129,000 | 0.04% |
| Shay Capital LLC | 60,000 | $257,000 | 0.03% |
| Walleye Capital LLC | 231,037 | $991,000 | 0.03% |
| BOOTHBAY FUND MANAGEMENT, LLC | 212,700 | $912,000 | 0.02% |